tetano
Editor, Senior Moderator
Emerg Infect Dis. 2018 Oct;24(10):1910-1913. doi: 10.3201/eid2410.180403.
[h=1]Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus.[/h] Hatta M, Zhong G, Chiba S, Lopes TJS, Neumann G, Kawaoka Y.
[h=3]Abstract[/h] The recent emergence of highly pathogenic influenza A(H7N9) variants poses a great risk to humans. We show that ferrets vaccinated with low pathogenicity H7N9 virus vaccine do not develop severe symptoms after infection with an antigenically distinct, highly pathogenic H7N9 virus. These results demonstrate the protective benefits of this H7N9 vaccine.
[h=4]KEYWORDS:[/h] H7N9; highly pathogenic; influenza; low pathogenicity; vaccine; viruses
PMID: 30226171 DOI: 10.3201/eid2410.180403
Free full text
[h=1]Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus.[/h] Hatta M, Zhong G, Chiba S, Lopes TJS, Neumann G, Kawaoka Y.
[h=3]Abstract[/h] The recent emergence of highly pathogenic influenza A(H7N9) variants poses a great risk to humans. We show that ferrets vaccinated with low pathogenicity H7N9 virus vaccine do not develop severe symptoms after infection with an antigenically distinct, highly pathogenic H7N9 virus. These results demonstrate the protective benefits of this H7N9 vaccine.
[h=4]KEYWORDS:[/h] H7N9; highly pathogenic; influenza; low pathogenicity; vaccine; viruses
PMID: 30226171 DOI: 10.3201/eid2410.180403
Free full text